}

Bids Are Invited For Cfa Re123 Divalproex Sodium Cr 500Mg Tab , Doxepin 25Mg Cap , Eye Drop Tobramycin 0.3Percent 5Ml , Tab Frusemide 40 Mg Tablet , Gatifloxacin 0.3Percent Eye Drop Bott Of 5Ml , Tab Imatinib Mesylate 100Mg Tablet , Isosorbide Dinitr, Delhi-Delhi

Indian Army has published Bids Are Invited For Cfa Re123 Divalproex Sodium Cr 500Mg Tab , Doxepin 25Mg Cap , Eye Drop Tobramycin 0.3Percent 5Ml , Tab Frusemide 40 Mg Tablet , Gatifloxacin 0.3Percent Eye Drop Bott Of 5Ml , Tab Imatinib Mesylate 100Mg Tablet , Isosorbide Dinitr. Submission Date for this Tender is 30-12-2024. Medicine Tenders in Delhi Delhi. Bidders can get complete Tender details and download the document.




Tender Notice

46529183
Bids Are Invited For Cfa Re123 Divalproex Sodium Cr 500Mg Tab , Doxepin 25Mg Cap , Eye Drop Tobramycin 0.3Percent 5Ml , Tab Frusemide 40 Mg Tablet , Gatifloxacin 0.3Percent Eye Drop Bott Of 5Ml , Tab Imatinib Mesylate 100Mg Tablet , Isosorbide Dinitr
Tender
Indian
Delhi
Delhi
30-12-2024

Tender Details

Bids Are Invited For Cfa Re123 Divalproex Sodium Cr 500Mg Tab , Doxepin 25Mg Cap , Eye Drop Tobramycin 0.3Percent 5Ml , Tab Frusemide 40 Mg Tablet , Gatifloxacin 0.3Percent Eye Drop Bott Of 5Ml , Tab Imatinib Mesylate 100Mg Tablet , Isosorbide Dinitrate 10Mg Tab , Mycophenolte Sodium 250Mg Tab , Oint Clobetasole 0.05Percent Plus Salicylic Acid 3.5Percent Plus Propylene Glycol Oint Tube Of 20Gm , Tab Lacosamide 100Mg Tablet Pioglitazome 15Mg Tab, Bethanechol 25Mg Tab , Total Quantity : 23657

Key Value

Document Fees
Refer document
EMD
Refer document
Tender Value
Refer document
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail